Many clinical trials, including those related to autism, do not report their results within a year of their completion.
Spectrum: Autism Research News
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can’t we tell if these medications work similarly in children with the condition?
Few of the most popular early treatments for autism are supported by strong evidence, according to two new studies.
Some scientists say an immune condition called PANDAS affects as many as 1 in 200 children who have traits similar to those of autism. But many experts contest that figure — and even the condition’s very existence.
Here are seven Spectrum stories from this year that deserve a close look.
No diet is likely to treat autistic people on a large scale, but diets based on a genetic profile may bring big benefits to a few.
Two agency letters put California-based Liveyon on warning and alert the public to the risks associated with stem-cell based therapies for autism.